Summary
The oestrogenic component of oral contraceptives affects the activity of liver enzymes and the concentrations of plasma proteins implicated in steroid metabolism and transport. The present study was designed to determine these effects on the kinetics of prednisone and prednisolone. After an oral dose of prednisone, women on oral contraceptive steroids (n=10) had higher mean (±SD) area under the plasma concentration versus time curves of total (428±67 µg/ml/min vs 188±28 µg/ml/min, p<0.001) and unbound prednisolone (64±10 µg/ml/min vs 41±10 µg/ml/min, p<0.001) than women not taking oral contraceptive steroids (n=10). The differences were attributable to a lower non-renal clearance of prednisolone and to a higher apparent systemic availability of the drug in contraceptive users than in the controls. The affinity of albumin and transcortin for prednisolone was lower in women on oral contraceptives than in controls (p<0.001). Thus, altered kinetics and protein binding may account for the known increase in glucocorticoid efficacy by oestrogens.
Similar content being viewed by others
References
Jenkins JS, Sampson PA (1967) Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J 2: 205–207
Fothersby K, James F (1972) Metabolism of synthetic steroids. Adv Steroid Biochem Pharmacol 3: 124–165
Westphal U (1969) Corticosteroid-binding globulin and other steroid-binding serum/proteins. In: Clayton RB (ed) Methods in enzymology, XV. Steroids and terpenoids. Academic Press, New York London, pp 761–796
Wagner JG, Wexler D, Agabeyoglu IT, Bergstrom RF, Sakmar E, Kay DR (1981) Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy. J Lab Clin Med 97: 487–501
Pardrigde WM (1981) Transport of protein-bound hormones into tissues in vivo. Endocr. Rev 2: 103–123
Katz FH, Kappas A (1967) The effects of estradiol and estriol on plasma levels of cortisol and thyroid hormone-binding globulins and on aldosterone and cortisol secretion rates in man. J Clin Invest 46: 1768–1777
Roy S, Mishell DR, Gray G, Takano RD, Brenner P, Eide I, Quattro V, Shaw ST (1980) Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Am J Obstet Gynecol 136: 920–931
Lipman MM, Katz FH, Jailer JW (1962) An alternate pathway for cortisol metabolism: 6β-hydroxycortisol production by human tissues slices. J Clin Endocr Metab 22: 268–272
Frey FJ, Frey BM, Benet LZ (1979) Liquid chromatographic measurement of endogenous and exogenous glucocorticoids in plasma. Clin Chem 25: 1944–1948
Frey FJ, Frey BM, Greither A, Benet LZ (1980) Prednisolone clearance at steady-state in dogs. J Pharmacol Exp Ther 215: 287–291
Behm HL, Wagner JG (1979) Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res Commun Chem Path Pharmacol 26: 145–160
Frey BM, Frey FJ (1982) Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion. Br J Clin Pharmacol 13: 245–249
Frey BM, Frey FJ (1982) Simultaneous measurement of prednisone, prednisolone and 6β-hydroxyprednisolone in urine by high performance liquid chromatography coupled with a radioactivity detector. J Chromatogr 229: 283–292
Oppenheimer JH, Schwartz HL, Surks MI (1975) Determination of common parameters of iodothyronin metabolism and distribution in man by noncompartmental analysis. J Clin Endocrinol Metabol 41: 319–324
Muldoon TG, Westphal V (1967) Steroid-protein interactions XV, isolation and characterization of corticosteroid-binding globulin from human plasma. J Biol Chem 242: 5636–5643
Putman FW (1975) The plasma proteins: structure, function and genetic control. Academic Press, New York, p 26
Pickup ME, Lowe JR, Leathan PA, Moffatt J, Brien R (1977) Dose dependent pharmacokinetics of prednisolone. Eur J Clin Pharmacol 12: 213–218
Legler UF, Frey FJ, Benet LZ (1982) Prednisolone clearance at steadystate in man. J Clin Endocr Metabol 55: 762–767
Frey FJ, Frey BM (1982) Altered prednisolone kinetics in patients with the nephrotic syndrome. Nephron 32: 45–48
Frey FJ, Frey BM (1984) Altered plasma protein binding of prednisolone in patients with the nephrotic syndrome. Am J Kidney Dis (in press)
Somogyi A, Eichelbaum M, Gugler R (1982) Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data. Eur J Clin Pharmacol 22: 85–90
Boekenoogen SJ, Szefler SJ, Jusko WJ (1983) Prednisolone disposition and protein binding in oral contraceptive users. J Clin Endocr Metabol 56: 702–709
Frey FJ, Frey BM (1983) Urinary excretion of 6β-hydroxyprednisolone an indicator of an enhanced non-renal prednisolone clearance rate. J Lab Clin Med 101: 593–604
Frey FJ, Amend WIC, Lozada JF, Frey BM, Holford NHG, Benet LZ (1981) Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non cushingoid patients. Eur J Clin Pharmacol 21: 235–243
Sheiner LB, Tozer TN (1978) Clinical pharmacokinetics: the use of plasma concentrations of drugs. In: Melmon KL, Morelli HF (eds) Clinical pharmacology. Macmillan, New York, pp 71–110.
Frey FJ, Lozada F, Guentert T, Frey BM (1981) A single dose of azathioprine does not affect pharmacokinetics of prednisolone. Eur J Clin Pharmacol 19: 209–213
Gambertoglio J, Frey FJ, Holford N, Amend WJC (1982) Prednisone and prednisolone bioavailability in renal transplant patients. Kidney Int 21: 621–626
Frey FJ, Amend WJC, Lozada F, Frey BM, Benet LZ (1981) Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone. J Clin Endocr Metab 53: 1076–1080
Brooks SM, Werk EE, Ackerman SJ, Sullivan I, Thrasher K (1972) Adverse effects of pheobarbital on corticosteroid metabolism in patients with bronchial asthma. N Engl J Med 286: 1125–1128
Brooks PM, Buchanan WW, Grove M, Downie WW (1976) Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study. Ann Rheum Dis 35: 339–343
Wassner SJ, Penrinin AJ, Malekzadeh MH, Fine RN (1976) The adverse effect of anticonvulsant therapy on renal allograft survival. J Pediatr 88: 134–137
Buffington GA, Dominguez JH, Piering WF (1976) Interaction of rifampin and glucocorticoids: adverse effect on renal allograft function. J Am Med Assoc 236: 1958–1960
Kozower M, Veatch L, Kaplan MM (1974) Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab 38: 407–412
Gambertoglio J, Vincenti F, Feduska N, Birnbaum J, Salvatierra O, Amend W (1980) Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. J Clin Endocr Metab 51: 561–565
Nelson DH, Tanney H, Mestman G, Gieschen VW, Wilson LD (1963) Potentiation of the biologic effect of administered cortisol by estrogen treatment. J Clin Endocrinol Metab 23: 261–263
Spangler AS, Antoniades HN, Sotman SL, Inderbitzing TM (1969) Enhancement of the antiinflammatory action of hydrocortisone by estrogen. J Clin Endocrinol Metab 29: 650–655
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frey, B.M., Schaad, H.J. & Frey, F.J. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone. Eur J Clin Pharmacol 26, 505–511 (1984). https://doi.org/10.1007/BF00542149
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542149